810192C
16:0-06:0 NBD PS
Manufacturer: Sigma Aldrich
CAS Number: 384833-06-1
Synonym(S): 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoserine (ammonium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 MG | 810192C-1-MG | In Stock | ₹ 55,355.85 |
810192C - 1 MG
In Stock
Quantity
1
Base Price: ₹ 55,355.85
GST (18%): ₹ 9,964.053
Total Price: ₹ 65,319.903
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 1 mL (810192C-1mg)
manufacturer/tradename
Avanti Polar Lipids 810192C
concentration
1 mg/mL (810192C-1mg)
shipped in
dry ice
storage temp.
−20°C
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 16:0-06:0 NBD PS | Sigma Aldrich | ₹ 60,749.90 | |
 | 384833-06-1 | 16:0-06:0 NBD PS (ammonium salt) | A2B Chem | -- |
Related Products
Description
- General description: Phosphatidylserine (PS) is a minor phospholipid present in the membranes of prokaryotic and eukaryotic cells. It comprises 2-10% of total phospholipids, enriched in brain.[1] NBD PS is labelled at the headgroup of PS with 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD).[2]
- Application: 16:0-06:0 NBD PS or 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoserine (ammonium salt) is suitable to measure the enzyme specificity of lipoteichoic acid (LTA) synthase (LtaS)[3][4] and in liposomes to determine the role of phospholipid scramblase 1 (PLSCR1) in phospholipid scrambling.[5]
- Biochem/physiol Actions: Phosphatidylserine (PS) contributes to the clearance of apoptotic cells.[6] It is involved in maintaining the nerve cell membrane and myelin sheath.[7] It is associated with cognitive disability in Alzheimer′s disease.[7]
- Packaging: 5 mL Amber Glass Screw Cap Vial (810192C-1mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810192C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810192C
concentration: 1 mg/mL (810192C-1mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810192C-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810192C
concentration:
1 mg/mL (810192C-1mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (810192P-1mg)
manufacturer/tradename: Avanti Polar Lipids 810192P
concentration: __
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (810192P-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810192P
concentration:
__
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810193C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810193C
concentration: 1 mg/mL (810193C-1mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810193C-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810193C
concentration:
1 mg/mL (810193C-1mg)
shipped in:
dry ice
storage temp.:
−20°C
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 1 mL (810194C-1mg)
manufacturer/tradename: Avanti Polar Lipids 810194C
concentration: 1 mg/mL (810194C-1mg)
shipped in: dry ice
storage temp.: −20°C
Assay:
>99% (TLC)
form:
liquid
packaging:
pkg of 1 × 1 mL (810194C-1mg)
manufacturer/tradename:
Avanti Polar Lipids 810194C
concentration:
1 mg/mL (810194C-1mg)
shipped in:
dry ice
storage temp.:
−20°C